A 16-week course of a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could consume without an ...

Findings showed 67% of the omalizumab group achieved the primary endpoint compared with 7% of the placebo group. Treatment with omalizumab, an anti-IgE antibody, significantly increased the amount of ...

Most of the drugs, plastics, and industrial materials widely used today are produced through chemical reactions. In general, most high-performance and sophisticated substances have complex structures, ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Omalizumab increased thresholds for reacting to peanut and other common allergenic foods during ...

The U.S. Food and Drug Administration approved the use of Xolair to reduce the severity of allergic reactions to one or more foods, making it the first FDA-approved medication to treat allergic ...

Patients are increasing their risk for adverse drug reactions by taking a growing number of prescription medicines, over-the-counter drugs and nutritional supplements. While adverse drug reactions ...

The optimization of reactions used to synthesize target compounds is pivotal to chemical research and discovery, whether in developing a route for manufacturing a life-saving medicine 1 or unlocking ...

(CNN) -- A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods. ...

Case Study Demonstrates Use of Xevo TQ MS for Bioanalytical Method Development The inherent sensitivity and specificity of LC/MS/MS has made it the technique of choice for bioanalysis. However, as ...

This new cerium-based catalyst interconverts between two oxidation states with distinct chemical properties, enabling two completely different reactions to occur in the same container. Most of the ...